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ZIKA VIRUS NONCODING SFRNA SEQUESTERS VIRAL RESTRICTION FACTORS INVOLVED IN RNA SPLICING  




ZIka virus (ZIKV) is a single-stranded positive sense RNA flavivirus that is transmitted primarily by 
Aedes aegypti. To date, all vector-borne flaviviruses are known to generate stable subgenomic flavivirus 
RNAs (sfRNA), due to the stalling of the major cytoplasmic 5’-3’ exoribonuclease XRN1 at a knot-like 
three helix junction structure located in viral 3’ untranslated regions (UTRs). Formation of sfRNAs not 
only stalls XRN1, but also represses its function. sfRNA decay intermediates accumulate to high levels in 
infected cells and studies with other flaviviruses have implicated sfRNAs in cytopathology. Our objective 
was to characterize the function of ZIKV sfRNAs to gain insight into ZIKV pathogenesis. Specifically, we 
identified host proteins that interact with ZIKV sfRNA and have begun to evaluate their role in 
cytopathology and pathogenesis. RNA pull-down experiments revealed that PHAX and SF3B1, critically 
important RNA splicing factors involved in nuclear-cytoplasmic shuttling, bind sfRNA. Additionally, the 
cytidine deaminase APOBEC3C was found to bind ZIKV sfRNA. Knockdown and subsequent 
overexpression of these RNA Binding Proteins (RBPs) identified the nucleic acid deaminase APOBEC3C 
and the splicing-associated factor PHAX as negative viral restriction factors whose activity may be 
suppressed and/or altered by sfRNA interaction during ZIKV infection. sfRNA interactions with the 
splicing factors also resulted in the accumulation of aberrantly spliced transcripts, possibly due to 
sequestration of the host cell proteins. Thus, in addition to targeting XRN1, sfRNAs appear to interact 
with a set of RBPs to disrupt cellular mRNA decay regulation as well as other RNA processing events in 
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 The Flaviviridae are single-stranded positive-sense RNA viruses which are responsible for an 
array of human diseases. An estimated 2/3rds of the world’s population is at risk for infection by one or 
more of the 35 flaviviruses which are known to cause disease. Arboviruses are the most recognized 
members of this virus family and utilize arthropod vectors as an important part of their transmission 
cycles. These viruses include Dengue virus (DENV), Japanese Encephalitis virus (JEV), Kunjin virus 
(KUNV), West Nile virus (WNV) and Zika virus (ZIKV). Flavivirus genomic RNA is typically between 10-
11kb, and contains a single large polyprotein-encoding open reading frame (ORF) flanked by 
untranslated regions (UTRs).  
 
 A key characteristic common to all arthropod-borne flavivirus infections is the generation and 
accumulation of a small, single 300-500 base subgenomic flavivirus RNA (sfRNA), which represents the 3’ 
UTR of the viral genomic RNA. sfRNA is not generated using a subgenomic promoter, but rather by 
stalling of the cellular 5’-3’ exoribonuclease XRN1 in its attempts to degrade viral, positive-sense 
transcripts within infected cells (Funk et al. 2010; Silva et al. 2010; Chapman et al. 2014a; Chapman et al. 
2014b). All arthropod-borne flaviviruses tested to date contain a three-helix junction knot-like structure 
in the proximal portion of their 3’ UTR that stalls XRN1 (Slonchak and Khromykh 2018). Interestingly, 
sfRNA generation results in repression of XRN1 activity in DENV and KUNV infection, presumably due to 
slow release of XRN1 from the knot-like RNA structure (Moon et al., 2012; 2015). sfRNA-mediated XRN1 
repression also appears to feedback in some fashion and shut down upstream functions of the decay 
pathway (Moon et al. 2012; Moon and Wilusz 2013; Steckelberg et al. 2018), where dysregulated gene 
expression results in stabilization of cellular mRNAs. This effect can be particularly dramatic for short-
lived mRNAs, such as cytokines and immune factors (Moon et al. 2012; Moon et al., 2015). The 
2 
abundant sfRNA in the cell can also serve as a sponge on which cellular RNA binding proteins can be 
sequestered, resulting in functional repression of a variety of RNA Binding Proteins (RBPs). To date, 
several cellular pathways that are targeted by sfRNA have been identified including innate immunity, 
interferon and RNA interference (Moon et al. 2015; Barnhart et al. 2013; Bidet et al. 2014; Bidet et al., 
2017; Funk et al., 2010; Hu et al., 2017). 
 
 ZIKV is a flavivirus which was discovered in 1947 in the forests of Uganda, and is transmitted by 
Aedes aegypti. The majority of ZIKV infections are asymptomatic, while those who do display symptoms 
typically have rash, mild fever, arthralgia and conjunctivitis (Hu et al., 2017; Petrova et al., 2019; Weger-
Lucarelli et al., 2017). In some instances, adults can even develop Guillain-Barre syndrome where the 
immune system mistakenly damages neuronal cells and can cause debilitating movement (Hu et al., 
2017). Notably, ZIKV infection during pregnancy can result in microcephaly, brain/eye abnormalities and 
even fetal loss due to the wide range of neurological damage that ZIKV causes (Hu et al., 2017; Weger-
Lucarelli et al., 2017). Flaviviral-associated pathogenesis mechanisms still largely remain unclear, and 
thus it is important to understand how these viruses interface with host-cell factors. 
 
 Gene expression regulation through post-transcriptional mechanisms is a complex cellular 
process which is critically important for maintaining cellular homeostasis. Therefore it is not surprising 
that many aspects of post-transcriptional control are targeted and disrupted by RNA viruses during 
infection (Moon et al., 2012; Petrova et al., 2019). For instance, RNA splicing is a highly regulated post-
transcriptional process that relies on the proper localization of the macromolecular complex known as 
the spliceosome in order to avoid aberrant splicing events within the cell (Wu et al., 2018). Mutations in 
the splicing factors SF3B1, a component of the U2 snRNP, can induce alternative splice sites in a subset 
of targeted host cell genes (Darman et al. 2015; Wu et al 2018). Recent transcriptome analysis of ZIKV-
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infected human neural progenitor cells identified hundreds of instances where aberrant alternative 
splicing occurred in more than 200 different RNAs (Hu et al., 2017b). Precisely how a cytoplasmic virus 
such as ZIKV induces significant mis-splicing within infected cells remains unclear – and providing insight 
into these mechanisms was one of the goals of this thesis. 
 
 Likewise, other aspects of post-transcriptional control can be impacted by RNA virus infections. 
The cellular mRNA decay machinery, a fundamental regulator of both quantity and quality of gene 
expression (Schoenberg and Maquat 2012), can also be targeted (Schoenberg et al., 2012). mRNA decay 
begins with deadenylation of the transcript, followed by the decapping of the 7-methylguanosine cap 
(Schoenberg et al., 2012). The monophosphorylated transcript is then reduced to single nucleotides via 
the action of the highly processive cytoplasmic 5’-3’ exoribonuclease XRN1 (Schoenberg et al., 2012). 
Evidence has mounted revealing that transcripts of RNA viruses are also actively targeted by the cellular 
RNA decay machinery (Moon and Wilusz 2013). Thus, any alteration in the cell’s ability to regulate RNA 
decay can have dramatic effects on the outcome and pathogenesis associated with viral infection.  
 
 Finally, RNA editing can also have an impact on viral infections, as it can greatly expand the 
coding capacity of the transcriptome (Kung et al., 2018).  The process consists of the deamination of 
adenosine to inosine (decoded as guanosine) or a cytosine to uracil and is catalyzed by one of two 
classes of deaminases: ADAR family enzymes that catalyze A to I (read as G) editing, and AID/APOBEC 
family of enzymes that catalyze C to U (Lerner et al. 2018).  RNA editing activity has been reported in 
APOBEC1, APOBEC3A (Sharma et al. 2015), and APOBEC3G (Sharma et al. 2016), but not for other 
members of the family to date. APOBEC3G has been implicated as a major restriction factor for 
retroviruses (Zhu et al., 2015).  There is also some evidence that APOBEC3H has antiviral functions 
against hepatitis C virus (HCV), a member of the Flaviviridae family of viruses (Peng et al., 2011).  
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 The purpose of this study was to catalogue major RNA binding proteins which interact with 
sfRNA generated during ZIKV infection and provide foundational data for potential molecular 
mechanisms of sfRNA-associated pathology. In this study we demonstrate that ZIKV infection in human 
cells leads to the accumulation of sfRNA which selectively associates with over 20 RNA binding proteins 
which affect a wide range of post-transcriptional cellular processes. We discovered that sfRNA 
associated with host cell splicing factors PHAX and SF3B1, as well as the cytidine deaminase APOBEC3C. 
Interestingly, SF3B1-mediated RNA splicing was shown to be significantly dysregulated during ZIKV 
infection leading to the production of novel, aberrantly spliced transcripts. Thus, generation of sfRNA 
during ZIKV infection appears to not only stall and subsequently repress the function of the 5’-3’ cellular 
exoribonuclease XRN1, but also appears to act as a protein sponge for a multitude of host RNA binding 
proteins. By disrupting aspects of cellular gene expression, ZIKV infection hinders the cell’s ability to 













MATERIALS AND METHODS: 
 
PCR/cloning/plasmid generation:   
Cloning for FLAG-tagged protein over-expression:  
 The p3XFLAG-CMV™- 10 Expression Vector (Sigma-Aldrich: #E7658) was used for generating 3x 
N-terminal FLAG-tagged proteins transfected into HEK293T cells. cDNA from HEK293T cells was used as 
template for the PCR-based amplification of select genes using sequence-specific primers engineered 
with restriction sites at their 5’ & 3’ ends to allow for ligation into the polylinker region of p3XFLAG-
CMV™-10 Expression Vector (See Table 1 for a detailed list of all primer sequences used in this study). 
 
Table 1: N Terminal 3x-FLAG Tag Cloning Primers 
Primer Sequence (5’-3’) 
APOBEC3C EcoR1 - Forward GATCGAATTCAAATCCACAGATCAGAAACCC 
APOBEC3C BamH1 - Reverse TCGCGGATCCTCACTGGAGACTCTCCCGTA 
PHAX EcoR1 - Forward GATCGAATTCAGCGTTGGAGGTCGGCGATATG 




Cloning and sequence analysis of alternatively spliced products: 
 cDNA from mock-infected (control) or ZIKV-infected (48 hours post infection) HEK293T cells was 
used as template for the PCR-based amplification of the human SRSF7 gene region spanning exons 2-8 
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using the following specific primers: SRSF7 Exon 2 Forward: 5’-GAA CTA TCG ACA GGC ATG CC-3’; SRSF7 
Exon 8 Reverse: 5’- CTT CTG CGA GGA CTT CCT GAT-3’. PCR products were separated via agarose gel 
electrophoresis.  Novel PCR products of interest were excised from the gel, purified using the Wizard SV 
Gel and PCR extraction kit (Promega-Ref#A9281), and sequenced via Sanger sequencing. Sequencing 
reads were aligned using Serial Cloner software (version 2.6.1). 
 
Table 2: SRSF7 Splice Check Primers 
Primer Sequence 
SRSF7 Sequencing Reverse CTTCTGCGAGGACTTCCTGAT 




Cell lines and virus propagation: 
 Human embryonic kidney 293T (HEK293T) and African green monkey (Cercopithecus aethiops) 
kidney cells (Vero) were maintained in Dulbecco’s Modified Eagle’s medium (DMEM; Mediatech-
Corning) supplemented with 10% newborn calf serum (NBCF; Peak Serums), 1% streptomycin/penicillin 
(Fisher Scientific-Hyclone), 0.5% L-glutamine (Fisher Scientific-Hyclone) and incubated at 37°C in the 
presence of 5% CO2. Human choriocarcinoma (JAR) cells were maintained in RPMI1640 1x with L-
glutamine (Corning: Ref 10-040-CV) supplemented with 10% newborn calf serum (NBFC; Peak Serums), 
1% streptomycin/penicillin (Fisher Scientific-Hyclone), and 0.5% L-glutamine (Fisher Scientific-Hyclone), 
and incubated at 37°C in the presence of 5% CO2. HEK293T, Vero, and JAR cells were routinely passaged 
(every 72-96 hours) by washing the monolayer with cold 1X-phosphate buffered saline (PBS; Corning) 
followed by incubation at 37°C with a 0.25% trypsin solution (Fisher Scientific-Hyclone) until the cells 
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detached. Cells and buffer were then diluted 1:1 with fresh media, transferred to a 15mL conical tube 
and centrifuged at 500xg for five minutes. The cell pellet was resuspended in fresh media by pipetting 
and routinely passaged at a 1:10 dilution. 
 
RNA pull-downs of associated protein factors: 
 1ug of each in vitro transcribed, biotinylated ZIKV 3’ UTR, DENV-2 3’ UTR and pGEM-sequence 
derived (control) RNA was used as starting material for the RNA pull-down. 100uL of uMacs Streptavidin 
magnetic beads (Miltenyi Biotech) was added to each of the biotinylated RNA preparations, and tubes 
were incubated at room temperature on a table-top rocker for 10min to allow biotinylated-RNAs to bind 
the streptavidin magnetic beads. Next, 350uL of pre-cleared HeLa cell cytoplasmic extract supplemented 
with 5ul protease inhibitor cocktail (Sigma-Aldrich) was added to each reaction tube and incubated at 
4°C with rotation for 60min. uMacs magnetic bead columns (Miltenyi Biotech) were set-up in the 
supplied magnetic stand and equilibrated with 100uL of Protein Equilibration buffer (Miltenyi Biotech). 
The columns were rinsed 2X with 200uL Binding/Wash Buffer (10mM HEPES pH 7.0, 200mM KCL, 10% 
glycerol, 1mM EDTA, 1mM DTT, 0.5% Triton X-100, Ribolock RNase Inhibitor [1 U/μL] (Thermo Scientific). 
Reaction mixtures were then applied to the center of the equilibrated and washed column, and the 
flow-through collected in a separate 1.5mL microfuge tube. Columns were washed 4X with 1mL 
Binding/Wash buffer (Miltenyi Biotech). RNA-binding proteins (RBPs) were eluted from the RNAs via the 
addition of Binding/Wash buffer supplemented with 1M NaCl and collected in 1.5mL microfuge tubes. A 
10% SDS-PAGE gel was cast and run in a laminar flow hood to minimize contamination with external 
protein sources. Equal volumes of eluted RBPs plus 2X-SDS protein load dye (100 mM Tris-Cl (pH 6.8) 4% 
(w/v) SDS, 0.2% (w/v) bromophenol blue, 20% (v/v) glycerol), 200 mM dithiothreitol (DTT)), were mixed, 
boiled for 5min, and loaded into separate wells. Protein samples were run through the stack and just 
into the resolving gel before being Coomassie stained and visualized with destain (40% methanol, 10% 
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glacial acetic acid solution) solution.  Protein bands were excised from the gel, placed in a 1.5mL 
microfuge tube with 500uL destain and submitted to the Proteomics and Metabolomics Facility at 
Colorado State University for trypsin digestion and LC-MS/MS protein identification. 
 
Western Blotting: 
Sample cells were collected in 15mL conical tubes, spun at 500xg for 5min to pellet cells, and 
washed 2x with 10ml ice cold PBS. Washed cell pellets were resuspended in 1ml low-stringency RIPA 
buffer (50mM Tris - HCl pH7.5, 1% NP40, 0.5% sodium deoxycholate, 0.05% SDS, 1mM EDTA, 150mM 
NaCl) supplemented with 0.2mM PMSF and protease inhibitor cocktail (Sigma-Aldrich # P8340-5ML), 
transferred to a 1.5mL microfuge tube and incubated at 4°C  with rotation for 10min. Lysate was 
transferred to a 1.5mL microfuge tube, filtered through a 25-gauge needle to shear the chromatin, spun 
to pellet debris, and finally transferred to a new 1.5mL microfuge tube. Equal volume of lysate and 2X-
SDS load dye were mixed, boiled for 5 minutes and loaded onto a 10% SDS-PAGE gel. Proteins were 
transferred to PVDF membrane (Immobilon-P; Ref: IPVH00010) using a semi-dry electrophoretic transfer 
cell (Bio-Rad; Cat#1703940). Transferred blots were blocked in Blocking buffer (1X PBS-Tween 20 
solution supplemented with 5% powdered milk) for 60min at room temperature with rotation. Probing 
blots (see table 3 for details on antibodies):  5mL fresh blocking buffer + primary antibody was rotated 
with the blots for 60min at room temperature, then washed 3X 10min each with 1X PBS-Tween 20 
solution. 5mL fresh blocking buffer and secondary antibody was rotated with the blots for 60min at 
room temperature, washed 3X 10min each with 1X PBS-Tween 20 solution, then developed with 
SuperSignal West Dura extended duration substrate (Thermo Scientific-Ref:34075). Blots were imaged 




In-vivo formaldehyde crosslinking and RNA co-immunoprecipitation and analysis: 
10cm dishes of ZIKV-infected (48 hpi) HEK293T cells were scraped from the dish and collected in 
15mL conical tubes. Cells were washed once with complete media, 2X with 5mL ice-cold 1xPBS, and 
resuspended in 10mL 1xPBS. Formaldehyde (0.3% final concentration) was added to the tubes and 
incubated at room temperature with gentle rocking for 10min. 1.4mL of 2M glycine pH 7.0 was added 
and incubation continued for an additional five minutes. Cells were washed 2X with 5mL ice cold PBS, 
then whole cell lysate generated (see section on Western Blotting for detailed lysate prep). Lysate was 
pre-cleared by incubating with 20uL packed Protein A magnetic beads (NEB - #S1425S) for 1 hour at 4°C. 
Beads were separated from cleared supernatant using a magnetic separation rack (NEB#S1506S), and a 
portion of the lysate was set aside as “Input”. The remaining lysate was divided equally between two 
1.5mL E. tubes, and each tube of lysate diluted with 250uL low-stringency RIPA buffer + 10uL 
corresponding primary antibody in one tube and 10uL normal-rabbit IgG in the control tube (Santa Cruz 
Biotech-SC-2025). Tubes rotated with primary antibody for 1 hour at 4°C, then 20uL Protein A magnetic 
beads were added to each tube and the tubes incubated at 4°C for an additional hour. 
 
Table 3: Antibodies 
Protein Target Antibody Dilution Used 
(Western Blot) 
APOBEC3C APOBEC3C antibody 
(cat.#GTX102164) - GeneTex 
1:500 
PHAX Anti-PHAX (ab157096) - Abcam 1:1000 
SF3B1 Anti-SAP155 antibody (ab66774) - Abcam 1:1000 
GAPDH Anti-GAPDH, clone 6C5 – Millipore Sigma 1:1000 
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FLAG-tag Monoclonal ANTI-FLAG® M2– Millipore Sigma 
(F1804-200UG) 
1:1000 
Anti-Mouse 2oAb Goat anti-mouse IgG-HRP (sc2005) – Santa Cruz 
Biotech 
1:2500 





Bead Washes:  
Tubes were placed in the magnetic separation rack, supernatant removed and discarded, and 
beads washed 5x with 1mL high-stringency RIPA buffer (base recipe: 50mM Tris – HCl pH 7.5, 1% NP-40, 
1% sodium deoxycholate, 0.1% SDS, 1mM EDTA, 1M NaCl, 1M Urea) supplemented with 1mM PMSF and 
protease inhibitor cocktail (Sigma-Aldrich # P8340-5ML). Beads were resuspended in 100uL TEBS buffer, 
incubated at 70˚C for 45min to reverse crosslinking, and 300uL TRIzol (Invitrogen) added to each 100uL 
sample (in TEDS buffer). RNA extraction was done via the addition of 80uL chloroform to the TRIzol 
reagent, following the manufacturer's procedure. Reverse transcription was done using 1ug total RNA as 
described above. The abundance of GAPDH and ZIKV RNA was determined by quantitative digital 
droplet PCR using Bio-Rad’s QX200 Droplet Digital PCR System and QX200 EvaGreen ddPCR Supermix 
(Bio-Rad) for each primary antibody use to immunoprecipitated the targeted protein. The primers used 
were as follows: GAPDH forward: 5’-TCTT TTGCGTCGCCAGCCGA; GAPDH reverse: 5’-ACCAGGCGC 
CCAATACGACC; ZIKV RNA Forward: 5’-AGGATCATAGGTGATGAAGAAAAGT, ZIKV RNA Reverse: 5’- 
GCACCAATCTTAATGTTGTCAGG. QuantSoft software generates the absolute copy number of the target 
DNA molecule in copies/uL. First the data was normalized to GAPDH across all samples. Next, fold 
changes in the target gene were calculated comparing experimental samples to control treated samples. 
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The data shown represent the mean values from three independent experiments. P-values were 
determined by a Student’s t-test. 
  
Mass spectrometry: 
 LC-MS/MS protein identification was performed by the Proteomics and Metabolomics Facility at 
Colorado State University. Scaffold 4 software was used to analyze the mass spectrometry data. 
  
siRNA knockdown in ZIKV-infected HEK293T Cells: 
 10cm plates were seeded with HEK293T cells so that the plates were ~30% confluent at the time 
the experiment began. Day 1(1st siRNA hit): control siRNA or siRNAs-targeting specific cellular proteins 
were transfected into HEK293T cells using JetPrime transfection reagent (Polyplus) according to the 
manufacturer's instructions, then returned to the 37°C incubator for 24 hours. Day 2 (2nd siRNA hit): 
same procedure as Day 1. Day 3 (ZIKV infection + 3rd siRNA hit): decant and discard the HEK293T growth 
media and replace half the original volume with fresh HEK293T media. Infect cells by adding freshly 
thawed Zika virus (Multiplicity of Infection (MOI) of ~10) to the dish, gently rocking to evenly distribute 
the virus across the cellular monolayer and incubating at 37°C for 60min. Viral media was then decanted 
and discarded, cells were rinsed once with 5ml 1X PBS to remove any virus particles not taken up by the 
cells, and 10mL fresh HEK293T media added back to the cells. Cells were allowed to recover from the 
infection by incubating at 37°C for 1 hour. Following the 1 hour recovery period, plates were subjected 
to their 3rd siRNA transfection (same procedure as described for Day 1), then returned to the 37°C 
incubator for 48 hours. Day 5 (collecting cellular supernatant and harvesting cells): The media from each 
ZIKV-infected cell plate was collected in a 15mL conical tube, spun at 500xg for 5min to pellet any debris, 
and aliquoted into 1.5mL microfuge tubes in 1mL aliquots for use with focus forming assays. Cells were 
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harvested with TRIzol reagent (Invitrogen), adding 4mL to each 10cm plate, incubating at room 
temperature for 5min with gentle rocking and collecting in 1.5mL microfuge tubes in 1mL aliquots. 
  Total RNA was isolated from the TRIzol reagent following the manufacturer's protocol and 
treated with DNase I (Fermentas). Reverse transcription was done using 1 ug of total RNA with Improm-
II Reverse Transcriptase (Promega) and random hexamer primers to generate cDNA. The abundance 
levels of GAPDH mRNA, mRNAs targeted via the siRNAs for knockdown, and ZIKV RNA were determined 
by quantitative digital droplet PCR using the Bio-Rad QX200 Droplet Digital PCR System and QX200 
EvaGreen ddPCR Supermix. The primers used were as follows: GAPDH forward: 5’-TCTT 
TTGCGTCGCCAGCCGA; GAPDH reverse: 5’-ACCAGGCGC CCAATACGACC; ZIKV RNA Forward: 5’-
AGGATCATAGGTGATGAAGAAAAGT; ZIKV RNA Reverse: 5’- GCACCAATCTTAATGTTGTCAGG. The 
QuantSoft software (Bio-Rad) generates the absolute copy number of the target DNA molecule in 
copies/uL. First the data was normalized to GAPDH across all samples. Next, fold changes in the target 
gene were calculated comparing experimental samples to control treated samples. The data shown 
represent the mean values from three independent experiments. P-values were determined by a 
Student’s t-test. Total Protein (from the same sample) was isolated from the TRIzol reagent following 
the manufacturer's protocol. Protein pellets were resuspended in a 3:1 mixture of 8M urea : 1% SDS. 
Protein concentrations were determined using the Qubit 3.0 Fluorometer (Thermo Fisher) and 
accompanying Qubit Protein Assay Kit (Thermo Fisher). Equal weight of protein from each sample was 
then separated based on size via SDS-PAGE. Proteins were transferred to PVDF-membranes (Immobilon-
P; Ref: IPVH00010) using a semi-dry electrophoretic transfer cell (Bio-Rad; Cat#1703940). Transferred 
blots were blocked in blocking buffer (1X PBS-Tween 20 solution supplemented with 5% powdered milk) 
for 60min at room temperature with rotation. Probing blots (see table 3 for details on antibodies):  5mL 
fresh blocking buffer + primary antibody was rotated with the blots for 60min at room temperature or 
overnight at 4°C, then washed 3X 10min each with 1X PBS-Tween 20 solution. 5mL fresh blocking buffer 
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+ secondary antibody were rotated with the blots for 60min at room temperature, washed 3X 10 minute 
each with 1X PBS-Tween 20 solution, then developed with SuperSignal West Dura extended duration 
substrate (Thermo Scientific-Ref:34075). Blots were imaged using the Azure Sapphire Biomolecular 
Imager (Azure Biosystems). 
 
Table 4: siRNA Sequences 
siRNAs Sequence (5’-3’) 
APOBEC3C GAAACCAGGTGGATTCTGA 
PHAX 1 GUAUCAGCGAGGAACAAAUUA 
PHAX 2 GAGUAUAUAGCACAGGAUUUA 




Protein overexpression in ZIKV-infected HEK293T cells: 
 10cm plates were seeded with HEK293T cells so that the plates were ~30% confluent at the time 
the experiment began. Day 1 (1st DNA transfection): p3XFLAG-CMV™-10 Expression Vectors (Sigma-
Aldrich: #E7658) harboring one of the three identified mammalian protein gene sequences or no 
inserted sequence (Empty-Vector) were transfected into Hek293T cells using jetPrime transfection 
reagent (Polyplus) according to the manufacturer's instructions, then returned to the 37°C incubator for 
24 hours. Day 2 (2nd DNA transfection): same procedure as Day 1. Day 3 (ZIKV infection + 3rd DNA 
transfection): decant and discard the HEK293T growth media and replace half the original volume with 
fresh HEK293T media. Cells were infected by adding freshly thawed Zika virus (MOI of ~10) to the dish, 
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gently rocking the evenly distribute the virus across the cellular monolayer and incubating at 37°C for 
60min. Viral media was then decanted and discarded, cells were rinsed once with 5ml 1X PBS to remove 
any virus particles not taken up by the cells, and 10mL fresh HEK293T media added back to the cells. 
Cells were allowed to recover from the infection by incubating at 37°C for 1 hour. Following the 1 hour 
recovery period, plates were subjected to their 3rd DNA transfection (same procedure as described for 
Day 1), then returned to the 37°C incubator for 48 hours. Day 5 (collecting cellular supernatant and 
harvesting cells): The media from each ZIKV-infected cell plate was collected in a 15mL conical tube, 
spun at 500xg for 5min to pellet any debris, and aliquoted into 1.5mL microfuge tubes in 1mL aliquots 
for use in focus forming assays. Cells were harvested with TRIzol reagent (Invitrogen), adding 4mL to 
each 10cm plate, incubating at room temperature for 5 minutes with gentle rocking and collecting in 
1.5mL microfuge tubes in 1mL aliquots. Total RNA and Total Protein was isolated from each TRIzol 
sample as described in the siRNA knockdown in ZIKV infected HEK293T cells above. 
  
Virus Preparation: 
 All ZIKV infections were performed using ZIKV strain PRVABC59. Infectious Zika virus particles 
were obtained from infectious cDNA clones, described in detail in (Weger- Lucarelli al., 2017). 
Propagation of the virus was conducted in Vero cells as follows: 15cm dishes were seeded with enough 
Vero cells in cDMEM supplemented with 10% FBS and 12.5mM HEPES so that plates were ~70% 
confluent 24hr later. The next day media was removed from the plates and replaced with half the 
original volume of cDMEM supplemented with 2% FBS and 12.5mM HEPES. Zika virus (MOI of  ~0.1) was 
added to the media and rocked gently to evenly distribute the virus, then incubated at 37oC for 60min. 
The remaining volume of media (cDMEM supplemented with 2% FBS and 12.5mM HEPES) was then 
added back to the cells and plates were incubated at 37oC for ~72 hours. When ~50% of the cells were 
dead, media was collected in 15mL conical tubes, spun at 500xg for 5 minutes to pellet any cellular 
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debris, and aliquoted virus-containing media into 1mL aliquots and frozen at -80oC. Newly propagated 
Zika virus stocks were titered via focus forming assays as described in (Weger-Lucarelli et al., 2017). 
 
Table 5: ddPCR Primers 
Primer 
Targets 
Forward Primer (5’-3’) Reverse Primer (5’-3’) 
APOBEC3C GTGGGACAGGGACAAGCATA CCCGTCTTCCAGGAGACAAC 
PHAX ACAGGCTAGGGAACAGACCA TCACTACTCGGGCTATCAGGT 
SF3B1 CCCAGAGCGTCTTGATCCTT AGCTTTTTCTCGTAGCTGTTGC 
GAPDH TCTTTTGCGTCGCCAGCCGA ACCAGGCGCCCAATACGACC 
EDC3 ATTTCTCTCACCCGGCCTTTCC CGTAATGTCACCTGCCCTGAAG 
















ZIKV and DENV bind cellular RNA binding proteins involved in a multitude of post-transcriptional 
processes 
 A substantial amount of sfRNA in infected cells is generated as xrRNA structures in flavivirus 
genomic plus sense RNAs stall and repress XRN1 activity (Moon et al., 2012; Pijlman et al., 2008; Silva et 
al., 2010; Chapman et al., 2014). The extensive accumulation of these sfRNAs may also serve as a sponge 
to sequester cellular RNA binding proteins and influence host-virus interactions that subsequently 
impact cellular physiology. In fact, flavivirus sfRNAs have previously demonstrated the capacity to 
interact with proteins involved in interferon responses, translational regulation, RNAi and innate 
immunity (Moon et al., 2015; Lerner et al., 2018; Sharma et al., 2015; Sharma et al., 2016; Petrova et al., 
2019).  Thus we hypothesized that sfRNA may bind to a series of RNA binding proteins and may have a 
broader impact on the RNA biology of the host cell than previously anticipated.  To further elaborate the 
role of sfRNA and test this hypothesis, biotinylated RNA pulldown assays were performed in 
collaboration with Dr. Dan Michalski in the lab using ZIKV sfRNA, DENV sfRNA or control RNA and HeLa 
cytoplasmic extracts. In order to promote the identification of biologically relevant, high affinity 
interactions in this experiment, we instituted two requirements.  First, the pull down assays were 
performed under relatively stringent conditions using high (300mM) salt concentrations to enrich for 
interactions with higher stability.  Second, following protein identification by mass spectrometry, we 
only chose to pursue proteins that interacted with both DENV-2 and ZIKV sfRNA but not with the control 
transcript.  This selection should bias our future analyses towards proteins that had a general effect on 
flavivirus biology.  Using these criteria, 28 proteins were found to be associated with both ZIKV and 
DENV sfRNA, and 21 of the proteins identified were associated with RNA biological processes including 
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RNA decay, translation, splicing and editing (Fig. 1A and B).   These 21 proteins therefore became the 

















Figure 1: ZIKV and DENV-2 sfRNAs interact with a common set of 28 proteins that impact a variety of 
aspects of cellular post-transcriptional gene regulation.   
Biotinylated RNAs containing the DENV-2 3’ UTR, ZIKV sfRNA or a size-matched control transcript were 
incubated with HeLa cytoplasmic extracts.  Proteins that co-purified with the RNAs on streptavidin beads 
were identified by mass spectrometry.  Panel A: a Venn diagram depicting the number and commonality 
of human host-cell RNA-binding proteins identified via mass spectrometry for each RNA. Panel B shows 
the relationship of proteins that bound to both the ZIKV and DENV sfRNA to associated post-
transcriptional processes.  Panel C: ZIKV sfRNA directly binds to a variety of cellular RNA-binding proteins 
in infected cells. 293T cells were infected with ZIKV for 48 hrs. Formaldehyde was added to the cultures 
to stabilize RNA-protein complexes and total cell extracts were prepared. Antibodies to the cytidine 
deaminase APOBEC3C, RNA splicing factors PHAX and SF3B1, or normal rabbit IgG were added to the 
extracts to immunoprecipitate RNA-protein complexes. Co-purifying RNAs were analyzed by digital 
droplet RT-PCR using primers to the Zika virus sfRNA/3’-UTR. The abundance of ZIKV RNA co-
precipitated using the various antibodies was determined relative to the amount pulled down in the 











 I chose to focus my efforts in the areas of RNA splicing and editing.  Three representative 
proteins, APOBEC3C, PHAX and SF3B1, involved in RNA splicing and nucleic acid editing were validated 
as bona fide sfRNA interactions proteins by performing RNA co-immunoprecipitation experiments using 
protein specific antibodies and ZIKV infected cell extracts. As seen in Fig. 1C, antibodies to all 3 proteins 
co-precipitated ZIKV sfRNA significantly (7-15 fold) above the IgG control background. Therefore we 
conclude that both ZIKV and DENV sfRNA interact with these three proteins in a specific manner during 
infection and may sequester them, thus resulting in dysregulation of their associated post-
transcriptional processes.  
 
ZIKV sfRNA sequesters negative restriction factors involved in nucleic acid editing and RNA splicing  
 
 We focused on determining the effect of these three proteins, one nucleic acid deaminase and 
two of which are involved in RNA splicing, on ZIKV infection dynamics. APOBEC3C is a cytidine 
deaminase localized to both the nucleus and cytoplasm and has been implicated in deamination of C to 
T residues in single stranded DNA (Timilsina et al., 2018). A close relative of this protein has been 
implicated in post-transcriptional editing of C residues to U in RNA. PHAX is involved in U snRNA nuclear 
export for maturation in the cytoplasm (Mourao et al., 2010).  SF3B1is part of the U2 snRNP complex, a 
core component of the cellular splicing machinery. siRNA mediated knockdown of each of the three 
proteins was performed and significant reductions in levels of both mRNA and protein levels were 
observed (Fig. 2). SF3B1 knockdown unfortunately resulted in cells with poor growth characteristics and 
this factor was thus excluded from further analyses. As seen in Fig. 3A, APOBEC3C and PHAX knockdown 
resulted in a significant ~4X increase in ZIKV viral RNA in infected cells. To complement these results, 
focus forming assays were performed to observe the amount of mature/infectious virus actively being 
released by cells. As seen in Fig. 3B, a significant increase in viral titers was observed. Conversely, 2-fold 
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overexpression of these two proteins resulted in a significant decrease in ZIKV viral RNA alongside a 
significant reduction in viral titers. Thus we conclude that the nucleic acid deaminase APOBEC3C and the 
RNA splicing-associated factor PHAX are negative viral restriction factors for a ZIKV infection.  As 
discussed further below, we hypothesize that their activity may naturally be at least partially suppressed 

















Figure 2: siRNA mediated knockdown of the cytidine deaminase APOBEC3C and the RNA splicing 
factor PHAX 
Panel A: Representative western blot depicting endogenous APOBEC3C and PHAX protein levels in ZIK-
infected HEK 293T cells treated with either a control siRNA (siCON lanes),  or an siRNA targeting 
APOBEC3C (siAPO lane) or a siRNA targeting PHAX (siPHAX lane).  Band intensity was quantified using 
ImageJ and reported under each lane relative to the value obtained in the siCON sample.  Panel B: 
mRNA levels of APOBEC3C and PHAX after siRNA mediated knockdown compared to normal 
















Figure 3: Knockdown experiments indicate that APOBEC3C and PHAX are negative restriction factors 
for ZIKV replication. 
Panel A: The relative levels of ZIKV RNA in cells transfected with either a control siRNA (siCONTROL 
lane), a siRNA targeting APOBEC3C (siAPOBEC3C lane) or a siRNA targeting PHAX (siPHAX lane) were 
determined 48 hpi. The data are presented as fold change relative to the ZIKV RNA levels present in cells 
transfected with the control siRNA. Panel B: Focus forming assays using Vero cells infected with viral 
supernatant from the siRNA knockdown samples. The average number of foci per mL from three 
independent infections is shown. All data are the result of three independent biological experiments. * = 




























Figure 4: Exogenous expression of FLAG-tagged APOBEC3C and PHAX downregulate ZIKV replication 
and progeny virus production 
Panel A: N-terminal FLAG-tagged versions of APOBEC3C and PHAX were constructed using expression 
vectors and transfected into HEK 293T cells. The levels of the indicated proteins were determined by 
western blot. Panel B: The relative levels of ZIKV RNA in cells transfected with either empty vector, 
FLAG-APOBEC3C or FLAG-PHAX expression plasmids were determined 48 hpi. The data are presented as 
fold change relative to the ZIKV levels present in cells transfected with the empty vector. Panel C: Focus 
forming assay using Vero cells infected with viral supernatant from the FLAG-tagged vector samples 
noted above. The average number of foci per mL from three independent infections is shown. All data 














ZIKV infection results in dysregulation of canonical nuclear splicing patterns 
 
 Since sfRNA is sequestering two major cellular RNA splicing factors, we hypothesized that 
patterns of nuclear mRNA splicing may be significantly altered during ZIKV infection.  SF3B1, a splicing 
factor that interacts strongly with sfRNA (Fig. 1C), modulates splicing for a known number of direct 
targets, including SRSF7, a gene that encodes a member of the SR proteins involved in splicing (Darman 
et al., 2015). Based on published results showing that SF3B1 knock down had dramatic effects on the 
splicing of the SRSF7 pre-mRNA (Darman et al., 2015), we chose to evaluate splicing of exons 2-8 of 
SRSF7 in HEK 293T cells during ZIKV infection (Fig. 5A). Uninfected HEK 293T cells displayed canonical 
transcripts where exons 2-8 are consecutively joined together as previously reported (Fig. 5B). In 
comparison, 48 hours post infection with ZIKV (when a substantial amount of sfRNA has accumulated 
within the cell), two aberrantly spliced SRSF7 mRNA transcripts were detected (Fig. 5B). Sequencing of 
two of these aberrantly spliced transcripts indicated that their formation resulted from the use of 
cryptic 5’ and 3’ splice sites. As diagrammed in Fig. 5C, aberrantly spliced product #1 contained a 
truncated exon 3 and retained a portion of intron sequence attached to exon 4.  Aberrantly spliced 
product #2 lacked exon 3 completely and retained a portion of intron sequence attached to exon 4. Low 
amounts of a third aberrantly spliced product that contained exons 3-4, exon 6, and exon 8, while 
skipping exons 5 & 6 entirely was also obtained, which interestingly was the same aberrantly spliced 
product reported when SF3B1 was inhibited (Wu et al., 2018). Therefore we conclude that nuclear 
splicing is dysregulated during ZIKV infection in a fashion that is consistent with a mechanistic 






Figure 5: Splicing of a SF3B1 target gene is dysregulated during ZIKV infection 
Panel A: Diagrammatic representation of exons 1-8 of SRSF7.  The positions of the forward and reverse 
primers used to analyze splicing patterns is indicated.  Panel B.  Total RNA from uninfected or ZIKV 
infected (48 hpi) HEK 293T cells was collected and subjected to RT-PCR analysis using primers to amplify 
the region between exons 2-8 of the SRSF7 mRNA. Reaction products were electrophoresed on a 1% 
agarose gel and visualized by ethidium bromide staining. The M lanes represents a nucleic acid size 
marker and alternatively spliced products are indicated by the numbers at the right of the gel.  Panel C: 
PCR products were gel purified, cloned into a pGEM-T easy vector and sequenced.  The position of the 























Investigating the mechanistic implications of APOBEC3C-sfRNA interactions in ZIKV infection  
 
We then investigated potential changes in RNA editing due to sponging of APOBEC3C by ZIKV 
sfRNA through two different sequencing experiments. First, analysis of the base transversion ratios in a 
global RNA seq experiment comparing total RNA obtained at 12 hours post ZIKV infection and 72 hours 
post ZIKV infection failed to discern any difference in RNA editing (Fig. 6A). Second, sequencing of the 
ZIKV 3’ UTR of isolates derived from wild type cells as well as cells containing overexpressed levels of 
APOBEC3C also failed to show any evidence of increased RNA editing (Fig. 6B). Based on these data, we 
conclude that APOBEC3C and ZIKV sfRNA interaction does not appear to change C->U RNA editing in 
infected cells. The cytidine deaminase APOBEC3C may have other, non-enzymatic impacts on ZIKV 
infection, such as protein-protein interaction or DNA editing that may have an effect on viral replication 
efficiency. A similar non-enzymatic impact of APOBEC3G on hepatitis C virus has been recently 















Figure 6: Changes in G->U mutations in total RNA and ZIKV RNA do not change upon ZIKV infection or 
exogenous expression of APOBEC3C 
Panel A: Comparison of transversion ratios at early (12 hpi) against late (72 hpi) total RNA samples from 
ZIKV infected cells. Panel B: Number of mutations found in ZIKV infected WT HEK293T and ZIKV infected 
FLAG-APOBEC3C transfected cells. The ZIKV 3’ UTR was amplified from total RNA from both sets of cells, 










 An estimated 2/3rds of the world’s population is considered to be at risk of infection from the 
Flaviviridae family of viruses, which encompass a multitude of species including Dengue virus, Japanese 
encephalitis virus, West Nile virus, Tick-borne encephalitis virus and Zika virus (Pijlman et al., 2008). 
They are able to cause disease with an array of symptoms, from malaise that would usually be indicative 
of the common cold, to more serious neurological impairments such as Guillain-Barré syndrome and 
microcephaly (Weger-Lucarelli et al., 2017). Currently no therapeutic treatments exist for flavivirus 
infection. Thus, characterizing mechanisms by which flaviviruses evade the host innate-immune 
response and establish a productive infection is fundamentally important to the design, development 
and testing of novel flaviviral therapeutics.   
 
 To date, all arthropod-borne members of the Flaviviridae contain pseudoknot-containing three-
helix junction structures in their 3’ untranslated regions capable of stalling the cytoplasmic 5’ - 3’ 
exoribonuclease XRN1 (Pijlman et al., 2008; Schoenberg et al., 2012). Subsequently, the process of 
stalling XRN1 on these resistant RNA structures also represses its function, likely due to the slow release 
of the enzyme from the highly structured RNA. XRN1 repression results in a cascade of changes in RNA 
metabolism and RNA turnover as the cellular mRNA decay machinery is disrupted, causing changes in 
gene expression – in particular increasing both the abundance and stability of typically short-lived host 
cellular mRNAs (Moon et al., 2012). Previous work done by other members of the lab provided evidence 
that Zika virus sfRNA accumulation disrupts and impacts cellular mRNA decay, but I decided to broaden 
our perspective on the role of this non-coding viral RNA by focusing on a subset of human cellular 
proteins that directly interact with ZIKV sfRNA in vivo.  
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 Generally speaking, ZIKV sfRNA has two known biologically relevant functions during infection: 
the stalling / repression of XRN1 and the binding of cellular cytoplasmic factors as a protein “sponge”. By 
investigating sfRNAs role in protein sequestration, we uncovered that cellular factors bound to it are 
involved in vital host processes such as RNA decay, RNA splicing and nucleic acid editing. sfRNA-
mediated sequestration of the splicing factor SF3B1 leads to the production of novel aberrantly spliced 
transcripts on one of the proteins key targets, SRSF7 (Fig. 5). Interestingly, SRSF7 is also an RNA splicing 
regulatory factor (Wu et al., 2018).  Thus the aberrant splicing of SRSF7 may exponentially increase the 
impact of sfRNA on cellular RNA splicing.  This may benefit ZIKV growth as the host cell is less able to 
respond to infection by altering its gene expression repertoire.  The implications on cellular nucleic acid 
metabolism from sfRNA-APOBEC3C interactions are currently less clear.  Although data clearly 
demonstrate a strong sfRNA-APOBEC3C interaction (Fig. 1C), the interaction does not appear to alter C-
>U RNA editing in infected cells (Fig. 6). Thus the APOBEC3C deaminase may instead have a role in single 
strand DNA editing (Timilsina et al., 2018).  Alternatively, non-enzymatic functions of APOBEC3C may be 
involved, such as protein-protein interactions (Sharma et al., 2015; Sharma et al., 2016) that could 
possibly interfere with viral replication.  
 
 The targeting of XRN1 by flaviviruses appears to be a common strategy that is shared among 
several other families of RNA viruses.  Our lab has recently demonstrated that 3’ UTRs from 
phleboviruses and arenaviruses contain highly structured regions that are able to stall and subsequently 
repress XRN1 (Moon et al., 2015; Moon et al., 2012; Pijlman et al., 2008) Additionally, two segmented 
RNA plant viruses, Red clover necrotic mosaic virus and beet necrotic yellow vein virus, demonstrate a 
capacity to stall XRN1 (Iwakawa et al., 2008; Flobinus et al., 2016) due to xrRNA structures located 
within their genomes. Thus, exclusivity of interfacing with the cellular decay machinery to produce sub-
genomic RNA cannot be given to the Flaviviridae. In addition, preliminary modeling studies suggests that 
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all XRN1 stalling structures are not created equal (J. Kieft, personal communication).  The conservation 
of this XRN1 stalling strategy over multiple virus families from diverse evolutionary and host 
backgrounds suggests that it is an effective way of interfacing with the host cell. It will be interesting in 
the future to perform a comprehensive survey of RNA virus families to get the full picture of how RNA-
based pathogens interface with this enzyme. 
 
 By targeting the cytoplasmic 5’ - 3’ exoribonuclease XRN1, RNA viruses disrupt a major and 
important pathway of RNA decay that is responsible for regulating 20-50% of gene expression within the 
host cell (Cheadle et al., 2005; Garcia Martinez et al., 2004; Schwanhausser et al., 2011). Disrupting this 
pathway can significantly dysregulate host cell gene expression during viral infection and may 
potentially limit the cell’s ability to mount an active response against the virus. Additionally, some 
studies have suggested XRN1 as a possible mediator between the host transcriptional machinery and 
RNA decay machinery to properly modulate cellular gene expression (Haimovich et al., 2013; Sun et al., 
2013). Briefly, XRN1 may play a major role in ‘transcriptional buffering’ which promotes homeostasis of 
gene expression when changes occur in either the rate of synthesis or decay of a transcript.  Thus, the 
targeting and repression of XRN1 by RNA viruses could disrupt two distinct but linked biological 
processes – transcription and decay. Since RNA viruses replicate in the cytoplasm, XRN1 is highly 
accessible to the virus since it is a cytoplasmic enzyme. Thus by targeting XRN1, the virus does not need 
to facilitate RNA and protein transport into the nucleus to disrupt cellular transcription (Raices et al., 
2017). 
 
 Disruption of the cellular RNA decay pathway has broad effects on the dynamics of the major 
RNA decay pathway in the cell. Flavivirus-mediated XRN1 repression shuts down upstream functions of 
the decay pathway (Moon et al., 2012; Moon et al., 2015), including deadenylation and decapping, in 
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addition to exonucleolytic decay.  Thus when the enzyme is repressed, translatable capped and 
polyadenylated mRNAs, rather than deadenylated and decapped decay fragments, accumulate in the 
cell.  How repressing XRN1 affects upstream decay processes is unclear, but our sfRNA pulldown/mass 
spectrometry data does provide a potential major clue. The accumulated sfRNAs during infection serve 
as a sponge for numerous cellular RNA binding proteins (Sessions et al., 2013) including two critically 
important cellular RNA decay factors, DDX6 and EDC3.  Thus the sequestration of these proteins 
involved in decapping and coordination of translation and mRNA decay sheds insight into why upstream 
aspects of disruptions in RNA decay are compromised in flavivirus infections.  
 
  A key implication of the data provided in this thesis is that sfRNA-mediated sponging of other 
cellular factors may play a multi-faceted role in disrupting RNA biological processes in the infected cell.   
Accurate, efficient RNA splicing is critical for maintaining transcriptome integrity (DeMaio et al., 2016), 
with approximately 94% of human genes being alternatively spliced (Wang et al., 2008).  A recent 
genome wide transcriptome analysis examining DENV-infected HEK293T cells revealed an array of 
cellular mRNAs which were mis-spliced. Interestingly, there was a significant increase in intron retention 
among these transcripts. As seen in Fig. 5, we also observed intron retention as a major impact of ZIKV 
infection on splicing.  In addition to sfRNA-mediated sequestration of splicing factors, the DENV non-
structural protein 5 (NS5) has also been shown to specifically interact with proteins of the U5 small 
nuclear ribonucleoprotein particle (DeMaio et al., 2016).  This interaction was also implicated in 
reducing splicing efficiency. Mechanistic studies have indicated that binding of NS5 to the spliceosome 
reduces overall efficiency of pre-mRNA processing independent of NS5 enzymatic activities (DeMaio et 




A separate transcriptome wide analysis of ZIKV infected human neural progenitor cells (hNPC) 
looked for virally induced aberrant splicing events in cellular RNAs (Hu et al., 2017).  Interestingly, ZIKV 
infection induces significant changes in isoform expression, lncRNA expression, and a host of other 
alternative splicing events compared to mock infected cells. ZIKV-mediated RNA mis-splicing events in 
hNPCs appear overall to be similar to those observed in DENV interactions, suggesting that 
dysregulation of RNA splicing is a general strategy employed by flaviviruses, where it could prove to play 
a critical pro-viral role in ZIKV mediated pathogenesis. Therefore, it is intriguing to pin down the precise 
mechanism(s) by which this occurs during infection. 
 
 SF3B1 and PHAX proteins were found to be in complex with ZIKV and DENV sfRNAs and are both 
attractive cellular protein targets for cytoplasmic flaviviruses due to the fact that they shuttle between 
the nucleus and cytoplasm for proper function. PHAX is a cellular RNA splicing factor required for 
nuclear export of small nuclear RNAs (snRNAs) (Mourao et al., 2010). PHAX directly binds the snRNA in 
the nucleus, and with the addition of 4 other protein factors is able to form the pre-export complex 
(Mourao et al., 2010). Nuclear phosphorylation of PHAX is required for U snRNA export complex 
assembly and export into the cytoplasm. Once in the cytoplasm, PHAX dephosphorylation occurs which 
causes complex disassembly, and PHAX is then recycled back into the nucleus via the importin 
alpha/beta heterodimeric import receptor (Mourao et al., 2010). Thus, we hypothesize that 
sequestration of cytoplasmic PHAX by sfRNA likely interferes with cyclic nuclear shuttling of PHAX, 
subsequently inhibiting the protein’s ability to drive the nuclear export of U snRNAs. In addition, PHAX is 
involved in the intranuclear transport of snoRNAs to dense regions of mRNA processing activity (Mourao 
et al., 2010), Cajal bodies. Thus PHAX cytoplasmic sequestration could also limit the proteins ability to 
transport snoRNAs appropriately, altering the regulated RNA processing occurring in Cajal bodies. These 
hypotheses can be tested in the future by immunofluorescence and cellular fraction studies. 
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 SF3B1 is a cellular RNA splicing factor and a part of the U2 snRNP complex required for the 
major initial step of branchpoint recognition in mRNA splicing. SF3B1 has been categorized as a splicing 
factor, yet recent evidence suggests that it could also play a role in regulating transcription, chromatin 
modification and may even guide nascent transcripts to co-transcriptional splice sites (Kfir et al., 2015; 
Girard et al., 2012). Recently, researchers have begun to develop small designer molecules which aim to 
inhibit the function of this splicing protein and function as tumor-specific anticancer agents.  However, 
conflicting reports regarding the efficacy of these agents have been reported. Interestingly, after 
statistical analysis of SF3B1 inhibition, the primary effect observed by one group was intron retention 
among cellular RNAs (Yoshimoto et al., 2017). On the other hand, another group found SF3B1 inhibition 
leads to a considerable amount of exon skipping in spliced transcripts (Wu et al., 2017). Thus the effects 
of SF3B1 inhibition are still not well understood, but the results of our study imply that both intron 
inclusion and exon skipping may result from sfRNA-mediated sequestration of SF3B1 during a ZIKV 
infection.  
 
 The AID/APOBEC family of enzymes catalyze C-to-U deamination on single stranded DNA or 
RNA.  The APOBEC family of proteins are evolutionarily conserved and share the catalytic backbone of 
the zinc-dependent deaminase family. APOBEC1 has demonstrated DNA editing activity in mammalian 
cells, but it has also been shown that these effects can occur on herpesvirus and hepatitis viral DNA 
genomes (Gee et al., 2011; Gonzalez et al., 2009). DNA/RNA editing is a prevalent epitranscriptomic 
modification which has a wide range of effects on host cells and viruses that are still not fully 
understood. In HIV infected cells, human APOBEC3G serves a defensive role where the protein induces G 
to A hypermutations in the HIV-1 genome (Sheehy et al., 2002). Previously, others have reported that 
APOBEC3G serves as a cellular restriction factor against hepatitis C virus (HCV) (Peng et al., 2011). 
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Interestingly, APOBEC3G directly interfaces with the NS3 protein of HCV resulting in decreased NS3 
helicase activity (Zhu et al., 2015). Thus there is precedence in the literature for APOBEC-mediated 
replication restriction of RNA viruses, yet questions remain with regard to how APOBEC3C is actually 
restricting flavivirus infection. APOBEC3C may restrict ZIKV replication through other methods, perhaps 
through various protein-protein and/or protein-RNA interactions. Additionally, it us unknown whether 
APOBEC3C is packaged into ZIKV virions as APOBEC3G has been shown to be packaged with HIV virions. 
Experiments to assess this using purified virions have been planned for future studies. 
 
A closer analysis of the knockdown/overexpression data for APOBEC3C and PHAX on ZIKV 
replication in Figures 3 and 4 may reveal two functional implications.  First, an approximately 2X 
overexpression of either APOBEC3C or PHAX led to a ten-fold reduction in focus forming units. This lack 
of stoichiometry between the relative levels of protein expression and viral replication suggests that the 
factors are interfering with an amplifiable aspect of the infection such as a viral RNA polymerase.  
Second, the knockdown of these cellular factors only had a 2-4 effect on viral RNA or virion production.  
This effect may be lower than overexpression due to the idea that the sfRNA being made by the virus is 
already sequestering/inhibiting a large amount of the endogenous proteins in the infected cell.  Thus 
reducing the overall amount of the already virally-debilitated protein would be expected to have a 
limited effect.  Thus these data may be consistent with our model that sequestration of the proteins by 
sfRNA has a significant biological effect in the infected cell.  
 
 As seen in Fig. 1B, an additional 15+ RNA binding proteins were identified in our RNA-pull down 
and mass spectrometry experiment that have not been explored in greater depth to date. These RBPs 
include multiples host RNA splicing factors that could perform pivotal roles in mediating the significant 
degree of aberrant splicing induced by flavivirus infections in human cells. RTCB, a potentially important 
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protein identified in our experiments, is a tRNA splicing factor that is the catalytic component of the 
tRNA-splicing ligase complex. RTCB functions to directly join two spliced tRNA-halves into a single, 
mature tRNA molecule. Evidence suggests RTCB also possesses RNA ligase activity with the ability to 
target a broad range RNA species and has been specifically shown to ligate XBP1 fragments during 
endoplasmic reticulum stress (Lu et al., 2014; Nandy et al., 2017). 
 
 In summary, this thesis has revealed several key aspects of flavivirus biology, yet it is very clear 
that detailed molecular mechanisms responsible for flaviviral mediated cytopathology and pathogenesis 
remain to be pursued in the future. Our work clearly highlights the importance of the highly abundant 
virally-derived sfRNA transcripts and their role in cytopathology and pathogenesis, and overall the 
impact of sfRNA-mediated sequestration of proteins and their subsequent repression of their normal 
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